Genetic Basis for Activity Differences Between Vancomycin and Glycolipid Derivatives of Vancomycin

U S Eggert, N Ruiz, B V Falcone, A A Branstrom, R C Goldman, T J Silhavy, D Kahne, Ulrike Eggert

Research output: Contribution to journalArticlepeer-review

123 Citations (Scopus)

Abstract

Small molecules that affect specific protein functions can be valuable tools for dissecting complex cellular processes. Peptidoglycan synthesis and degradation is a process in bacteria that involves multiple enzymes under strict temporal and spatial regulation. We used a set of small molecules that inhibit the transglycosylation step of peptidoglycan synthesis to discover genes that help to regulate this process. We identified a gene responsible for the susceptibility of Escherichia coli cells to killing by glycolipid derivatives of vancomycin, thus establishing a genetic basis for activity differences between these compounds and vancomycin.
Original languageEnglish
Pages (from-to)361-364
Number of pages4
JournalScience
Volume294
Issue number5541
DOIs
Publication statusPublished - 12 Oct 2001

Keywords

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Drug Resistance, Microbial
  • Drug Resistance, Multiple
  • Enzyme Inhibitors
  • Escherichia coli
  • Genes, Bacterial
  • Genetic Complementation Test
  • Glycosylation
  • Hexosyltransferases
  • Lipoproteins
  • Microbial Sensitivity Tests
  • Mutation
  • N-Acetylmuramoyl-L-alanine Amidase
  • Oligosaccharides
  • Peptidoglycan
  • Peptidoglycan Glycosyltransferase
  • Phenotype
  • Vancomycin
  • Vancomycin Resistance

Fingerprint

Dive into the research topics of 'Genetic Basis for Activity Differences Between Vancomycin and Glycolipid Derivatives of Vancomycin'. Together they form a unique fingerprint.

Cite this